|The CDKN2A cdkn2a (Catalog #MBS152638) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s CDKN2A can be used in a range of immunoassay formats including, but not limited to, Blocking (BL).
CDKN2A peptide is used for blocking the activity of CDNK2A antibody. Researchers should empirically determine the suitability of the CDKN2A cdkn2a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The CDKN2A cdkn2a product has the following accession number(s) (GI #4502749) (NCBI Accession #NP_000068) (Uniprot Accession #P42771). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide
Location: 18 amino acids near the amino terminus of human CDNK2A. Blood, Bone, Brain, Cervix, Liver, Lung, Lymph, Lymph Node, Skin, Stomach tissues are correlated with this protein. CDKN2A also interacts with the following gene(s): CCND1, CDK2, CDK4, CDK6, MDM2, MYC, NPM1, TP53, UBC. The following patways have been known to be associated with this gene. Adenocarcinoma, Breast Neoplasms, Cell Transformation, Neoplastic, Glioma, Lung Neoplasms, Lymphoma, Neoplasms, Experimental, Pancreatic Neoplasms, Skin Neoplasms, Urogenital Neoplasms are some of the diseases may be linked to CDKN2A Peptide.